Pink SheetThe US Food and Drug Administration has a new message for industry representatives on advisory committees: You can be here, but don’t talk too much. Nonvoting representatives, including the industry r
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. JCR Adds $825m Gene Therapy Tech D
In VivoThree years after In Vivo identified AI in biologics as “an emerging frontier,” pharmaceutical companies are doubling down with billion-dollar partnerships and comprehensive internal platforms. Ye
In VivoRiding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com